2026-01-29 22:30:07 | [32mINFO    [0m | session:init_db:144 | Œì¬£√¥ pgvector extension enabled
2026-01-29 22:30:07 | [32mINFO    [0m | session:init_db:150 | Œì¬£√¥ pg_trgm extension enabled
2026-01-29 22:30:07 | [32mINFO    [0m | session:init_db:156 | Œì¬£√¥ Database tables created
2026-01-29 22:30:07 | [32mINFO    [0m | docling_utils:__init__:102 | DoclingParser initialized (OCR: True, Images: False)
2026-01-29 22:30:07 | [32mINFO    [0m | ingest:__init__:300 | IngestionPipeline initialized
2026-01-29 22:30:07 | [32mINFO    [0m | ingest:ingest_directory:643 | Found 4 PDFs in data/pdfs
2026-01-29 22:30:07 | [32mINFO    [0m | ingest:ingest_pdf:325 | Starting ingestion: 00062205.pdf
2026-01-29 22:30:07 | [32mINFO    [0m | docling_utils:parse:125 | Parsing PDF: 00062205.pdf (hash: c72295bc...)
2026-01-29 22:30:07 | [32mINFO    [0m | document:_guess_format:538 | detected formats: [<InputFormat.PDF: 'pdf'>]
2026-01-29 22:30:07 | [32mINFO    [0m | document_converter:_convert:449 | Going to convert document batch...
2026-01-29 22:30:07 | [32mINFO    [0m | document_converter:_get_pipeline:494 | Initializing pipeline for StandardPdfPipeline with options hash 4f39f3c2d53938e7a7298827020a1fe0
2026-01-29 22:30:07 | [32mINFO    [0m | base_factory:load_from_plugins:112 | Loading plugin 'docling_defaults'
2026-01-29 22:30:07 | [32mINFO    [0m | __init__:get_picture_description_factory:28 | Registered picture descriptions: ['vlm', 'api']
2026-01-29 22:30:07 | [32mINFO    [0m | base_factory:load_from_plugins:112 | Loading plugin 'docling_defaults'
2026-01-29 22:30:07 | [32mINFO    [0m | __init__:get_ocr_factory:18 | Registered ocr engines: ['auto', 'easyocr', 'ocrmac', 'rapidocr', 'tesserocr', 'tesseract']
2026-01-29 22:30:07 | [32mINFO    [0m | auto_ocr_model:__init__:77 | rapidocr cannot be used because onnxruntime is not installed.
2026-01-29 22:30:07 | [32mINFO    [0m | auto_ocr_model:__init__:96 | easyocr cannot be used because it is not installed.
2026-01-29 22:30:08 | [32mINFO    [0m | accelerator_utils:decide_device:96 | Accelerator device: 'cpu'
[INFO] 2026-01-29 22:30:08,205 [RapidOCR] base.py:22: Using engine_name: torch
[INFO] 2026-01-29 22:30:08,215 [RapidOCR] device_config.py:50: Using CPU device
[INFO] 2026-01-29 22:30:08,226 [RapidOCR] download_file.py:60: File exists and is valid: C:\G\Maclens chatbot w api\backend\venv\Lib\site-packages\rapidocr\models\ch_PP-OCRv4_det_infer.pth
[INFO] 2026-01-29 22:30:08,226 [RapidOCR] main.py:50: Using C:\G\Maclens chatbot w api\backend\venv\Lib\site-packages\rapidocr\models\ch_PP-OCRv4_det_infer.pth
[INFO] 2026-01-29 22:30:08,392 [RapidOCR] base.py:22: Using engine_name: torch
[INFO] 2026-01-29 22:30:08,392 [RapidOCR] device_config.py:50: Using CPU device
[INFO] 2026-01-29 22:30:08,392 [RapidOCR] download_file.py:60: File exists and is valid: C:\G\Maclens chatbot w api\backend\venv\Lib\site-packages\rapidocr\models\ch_ptocr_mobile_v2.0_cls_infer.pth
[INFO] 2026-01-29 22:30:08,392 [RapidOCR] main.py:50: Using C:\G\Maclens chatbot w api\backend\venv\Lib\site-packages\rapidocr\models\ch_ptocr_mobile_v2.0_cls_infer.pth
[INFO] 2026-01-29 22:30:08,458 [RapidOCR] base.py:22: Using engine_name: torch
[INFO] 2026-01-29 22:30:08,458 [RapidOCR] device_config.py:50: Using CPU device
[INFO] 2026-01-29 22:30:08,482 [RapidOCR] download_file.py:60: File exists and is valid: C:\G\Maclens chatbot w api\backend\venv\Lib\site-packages\rapidocr\models\ch_PP-OCRv4_rec_infer.pth
[INFO] 2026-01-29 22:30:08,482 [RapidOCR] main.py:50: Using C:\G\Maclens chatbot w api\backend\venv\Lib\site-packages\rapidocr\models\ch_PP-OCRv4_rec_infer.pth
2026-01-29 22:30:08 | [32mINFO    [0m | auto_ocr_model:__init__:113 | Auto OCR model selected rapidocr with torch.
2026-01-29 22:30:08 | [32mINFO    [0m | base_factory:load_from_plugins:112 | Loading plugin 'docling_defaults'
2026-01-29 22:30:08 | [32mINFO    [0m | __init__:get_layout_factory:36 | Registered layout engines: ['docling_layout_default', 'docling_experimental_table_crops_layout']
2026-01-29 22:30:10 | [32mINFO    [0m | accelerator_utils:decide_device:96 | Accelerator device: 'cpu'
2026-01-29 22:30:11 | [32mINFO    [0m | base_factory:load_from_plugins:112 | Loading plugin 'docling_defaults'
2026-01-29 22:30:11 | [32mINFO    [0m | __init__:get_table_structure_factory:46 | Registered table structure engines: ['docling_tableformer']
2026-01-29 22:30:11 | [32mINFO    [0m | accelerator_utils:decide_device:96 | Accelerator device: 'cpu'
2026-01-29 22:30:12 | [32mINFO    [0m | base_pipeline:execute:65 | Processing document 00062205.pdf
2026-01-29 22:30:57 | [32mINFO    [0m | document_converter:_convert:473 | Finished converting document 00062205.pdf in 49.66 sec.
2026-01-29 22:30:57 | [33mWARNING [0m | document:export_to_markdown:5007 | Parameter `strict_text` has been deprecated and will be ignored.
2026-01-29 22:30:57 | [32mINFO    [0m | docling_utils:parse:145 | Successfully parsed 00062205.pdf: 64623 chars, 0 images, 27 pages
2026-01-29 22:30:59 | [32mINFO    [0m | _client:_send_single_request:1026 | HTTP Request: POST https://jason-mj5zxtab-canadaeast.cognitiveservices.azure.com/openai/deployments/gpt-4o-agent/chat/completions?api-version=2024-12-01-preview "HTTP/1.1 200 OK"
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:extract:156 | Extracted drug: nizatidine (brand: axid, generic: nizatidine)
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:chunk:253 | Chunked into 63 sections
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 1/63: pr axid
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: pr axid
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 2/63: table of contents
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: table of contents
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 3/63: indications
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: indications
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 4/63: pediatrics
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: pediatrics
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 5/63: geriatrics
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: geriatrics
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 6/63: contraindications
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: contraindications
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 7/63: recommended dose and dosage adjustment
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: recommended dose and dosage adjustment
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 8/63: dose adjustment in renal impairment
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: dose adjustment in renal impairment
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 9/63: administration
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: administration
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 10/63: missed dose
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: missed dose
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 11/63: overdosage
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: overdosage
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 12/63: dosage forms strengths composition and packaging
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: dosage forms strengths composition and packaging
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 13/63: endocrine and metabolism
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: endocrine and metabolism
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 14/63: gastrointestinal
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: gastrointestinal
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 15/63: hepaticbiliarypancreatic
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: hepaticbiliarypancreatic
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 16/63: monitoring and laboratory tests
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: monitoring and laboratory tests
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 17/63: renal
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: renal
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 18/63: pregnant women
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: pregnant women
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 19/63: breast-feeding
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: breast-feeding
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 20/63: pediatrics
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 21/63: geriatrics
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 22/63: adverse reaction overview
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: adverse reaction overview
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 23/63: clinical trial adverse reactions
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: clinical trial adverse reactions
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 24/63: less common clinical trial adverse reactions
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: less common clinical trial adverse reactions
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 25/63: drug interactions overview
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: drug interactions overview
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 26/63: drug-drug interactions
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: drug-drug interactions
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 27/63: drug-food interactions
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: drug-food interactions
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 28/63: drug-herb interactions
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: drug-herb interactions
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 29/63: drug-laboratory test interactions
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: drug-laboratory test interactions
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 30/63: mechanism of action
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: mechanism of action
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 31/63: pharmacodynamics
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: pharmacodynamics
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 32/63: absorption
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: absorption
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 33/63: distribution
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: distribution
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 34/63: metabolism
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: metabolism
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 35/63: elimination
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: elimination
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 36/63: special populations and conditions
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: special populations and conditions
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 37/63: storage stability and disposal
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: storage stability and disposal
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 38/63: drug substance
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: drug substance
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 39/63: clinical trials
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: clinical trials
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 40/63: microbiology
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: microbiology
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 41/63: acute toxicity
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: acute toxicity
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 42/63: subacute toxicity
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: subacute toxicity
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 43/63: chronic toxicity
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: chronic toxicity
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 44/63: carcinogenicity
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: carcinogenicity
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 45/63: genotoxicity
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: genotoxicity
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 46/63: reproductive and developmental toxicology
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: reproductive and developmental toxicology
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 47/63: teratology
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: teratology
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 48/63: nizatidine capsules
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: nizatidine capsules
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 49/63: what is axid used for
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: what is axid used for
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 50/63: how does axid work
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: how does axid work
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 51/63: what are the ingredients in axid
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: what are the ingredients in axid
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 52/63: axid comes in the following dosage forms
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: axid comes in the following dosage forms
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 53/63: do not use axid if
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: do not use axid if
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 54/63: other warnings you should know about
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: other warnings you should know about
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 55/63: the following may interact with axid
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: the following may interact with axid
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 56/63: how to take axid
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: how to take axid
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 57/63: adults
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: adults
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 58/63: overdose
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: overdose
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 59/63: missed dose
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 60/63: what are possible side effects from using axid
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: what are possible side effects from using axid
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 61/63: reporting side effects
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: reporting side effects
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 62/63: storage
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: storage
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 63/63: if you want more information about axid
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: if you want more information about axid
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:ingest_pdf:409 | Completed ingestion: 00062205.pdf Œì√•√Ü 63 sections, 0 structures, 60 new section types
2026-01-29 22:30:59 | [32mINFO    [0m | ingest:ingest_pdf:325 | Starting ingestion: 00070963.pdf
2026-01-29 22:30:59 | [32mINFO    [0m | docling_utils:parse:125 | Parsing PDF: 00070963.pdf (hash: 2b0f46e6...)
2026-01-29 22:30:59 | [32mINFO    [0m | document:_guess_format:538 | detected formats: [<InputFormat.PDF: 'pdf'>]
2026-01-29 22:30:59 | [32mINFO    [0m | document_converter:_convert:449 | Going to convert document batch...
2026-01-29 22:30:59 | [32mINFO    [0m | base_pipeline:execute:65 | Processing document 00070963.pdf
2026-01-29 22:32:19 | [32mINFO    [0m | document_converter:_convert:473 | Finished converting document 00070963.pdf in 80.23 sec.
2026-01-29 22:32:20 | [33mWARNING [0m | document:export_to_markdown:5007 | Parameter `strict_text` has been deprecated and will be ignored.
2026-01-29 22:32:20 | [32mINFO    [0m | docling_utils:parse:145 | Successfully parsed 00070963.pdf: 158081 chars, 0 images, 49 pages
2026-01-29 22:32:21 | [32mINFO    [0m | _client:_send_single_request:1026 | HTTP Request: POST https://jason-mj5zxtab-canadaeast.cognitiveservices.azure.com/openai/deployments/gpt-4o-agent/chat/completions?api-version=2024-12-01-preview "HTTP/1.1 200 OK"
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:extract:156 | Extracted drug: metoprolol tartrate (brand: apo-metoprolol, generic: metoprolol tartrate)
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:chunk:253 | Chunked into 95 sections
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 1/95: pr apo-metoprolol
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: pr apo-metoprolol
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 2/95: pr apo-metoprolol type l
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: pr apo-metoprolol type l
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 3/95: recent major label changes
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: recent major label changes
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 4/95: table of contents
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 5/95: hypertension
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: hypertension
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 6/95: angina pectoris
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: angina pectoris
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 7/95: myocardial infarction
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: myocardial infarction
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 8/95: pediatrics
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 9/95: geriatrics
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 10/95: contraindications
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 11/95: apo-metoprolol apo-metoprolol type l metoprolol tartrate is contraindicated in patients with
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: apo-metoprolol apo-metoprolol type l metoprolol tartrate is contraindicated in patients with
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 12/95: myocardial infarction patients - additional contraindications
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: myocardial infarction patients - additional contraindications
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 13/95: dosing considerations
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: dosing considerations
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 14/95: hypertension
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 15/95: angina pectoris
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 16/95: in addition to the usual contraindications
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: in addition to the usual contraindications
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 17/95: early treatment
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: early treatment
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 18/95: late treatment for proven myocardial infarction patients only
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: late treatment for proven myocardial infarction patients only
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 19/95: pediatric patients
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: pediatric patients
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 20/95: renal impairment
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: renal impairment
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 21/95: hepatic impairment
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: hepatic impairment
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 22/95: geriatric patients gt65 years
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: geriatric patients gt65 years
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 23/95: administration
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 24/95: missed dose
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 25/95: symptoms
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: symptoms
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 26/95: management
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: management
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 27/95: dosage forms strengths composition and packaging
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 28/95: abrupt withdrawal
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: abrupt withdrawal
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 29/95: cardiovascular
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: cardiovascular
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 30/95: myocardial infarction - additional warnings
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: myocardial infarction - additional warnings
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 31/95: driving and operating machinery
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: driving and operating machinery
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 32/95: endocrine and metabolism
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 33/95: hepaticbiliarypancreatic
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 34/95: immune
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: immune
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 35/95: interactions
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: interactions
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 36/95: peripheral vascular disease
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: peripheral vascular disease
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 37/95: peri-operative considerations
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: peri-operative considerations
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 38/95: renal
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 39/95: respiratory
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: respiratory
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 40/95: skin
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: skin
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 41/95: pregnant women
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 42/95: breast-feeding
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 43/95: pediatrics
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 44/95: geriatrics
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 45/95: adverse reaction overview
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 46/95: clinical trial adverse reactions
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 47/95: clinical laboratory
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: clinical laboratory
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 48/95: hematology
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: hematology
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 49/95: post-market adverse reactions
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: post-market adverse reactions
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 50/95: nervous system disorders
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: nervous system disorders
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 51/95: investigations
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: investigations
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 52/95: serious drug interactions
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: serious drug interactions
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 53/95: drug-interactions overview
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: drug-interactions overview
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 54/95: drug-drug interactions
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 55/95: drug-food interactions
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 56/95: drug-herb interactions
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 57/95: drug-laboratory test interactions
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 58/95: mechanism of action
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 59/95: pharmacodynamics
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 60/95: effects on pulmonary function
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: effects on pulmonary function
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 61/95: pharmacokinetic and pharmacodynamic relationship
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: pharmacokinetic and pharmacodynamic relationship
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 62/95: pharmacokinetics
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: pharmacokinetics
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 63/95: absorption
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 64/95: distribution
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 65/95: metabolism
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 66/95: elimination
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 67/95: special populations and conditions
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 68/95: storage stability and disposal
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 69/95: drug substance
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 70/95: chemical name
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: chemical name
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 71/95: structural formula
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: structural formula
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 72/95: comparative bioavailability studies
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: comparative bioavailability studies
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 73/95: table 6 -acute toxicity
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: table 6 -acute toxicity
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 74/95: table 8 -long-term toxicity subacute
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: table 8 -long-term toxicity subacute
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 75/95: carcinogenicity
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 76/95: reproductive and developmental toxicology
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 77/95: supporting product monographs
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: supporting product monographs
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 78/95: pr apo-metoprolol
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 79/95: metoprolol tartrate film-coated tablets
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: metoprolol tartrate film-coated tablets
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 80/95: what is apo-metoprolol apo-metoprolol type l used for
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: what is apo-metoprolol apo-metoprolol type l used for
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 81/95: how does apo-metoprolol apo-metoprolol type l work
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: how does apo-metoprolol apo-metoprolol type l work
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 82/95: what are the ingredients in apo-metoprolol apo-metoprolol type l
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: what are the ingredients in apo-metoprolol apo-metoprolol type l
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 83/95: apo-metoprolol apo-metoprolol type l comes in the following dosage forms
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: apo-metoprolol apo-metoprolol type l comes in the following dosage forms
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 84/95: do not use apo-metoprolol apo-metoprolol type l if
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: do not use apo-metoprolol apo-metoprolol type l if
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 85/95: other warnings you should know about
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 86/95: the following may also interact with apo-metoprolol apo-metoprolol type l
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: the following may also interact with apo-metoprolol apo-metoprolol type l
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 87/95: how to take apo-metoprolol apo-metoprolol type l
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: how to take apo-metoprolol apo-metoprolol type l
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 88/95: usual dose
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: usual dose
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 89/95: the usual adult maintenance doses are
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: the usual adult maintenance doses are
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 90/95: overdose
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 91/95: missed dose
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 92/95: what are possible side effects from using apo-metoprolol apo-metoprolol type l
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: what are possible side effects from using apo-metoprolol apo-metoprolol type l
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 93/95: reporting side effects
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 94/95: storage
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:479 | Processing section 95/95: if you want more information about apo-metoprolol apo-metoprolol type l
2026-01-29 22:32:21 | [32mINFO    [0m | ingest:_store_sections:489 | Discovered new section type: if you want more information about apo-metoprolol apo-metoprolol type l
2026-01-29 22:32:22 | [32mINFO    [0m | ingest:ingest_pdf:409 | Completed ingestion: 00070963.pdf Œì√•√Ü 95 sections, 0 structures, 56 new section types
2026-01-29 22:32:22 | [32mINFO    [0m | ingest:ingest_pdf:325 | Starting ingestion: 00062205.pdf
2026-01-29 22:32:22 | [32mINFO    [0m | docling_utils:parse:125 | Parsing PDF: 00062205.pdf (hash: c72295bc...)
2026-01-29 22:32:22 | [32mINFO    [0m | document:_guess_format:538 | detected formats: [<InputFormat.PDF: 'pdf'>]
2026-01-29 22:32:22 | [32mINFO    [0m | document_converter:_convert:449 | Going to convert document batch...
2026-01-29 22:32:22 | [32mINFO    [0m | base_pipeline:execute:65 | Processing document 00062205.pdf
2026-01-29 22:33:04 | [32mINFO    [0m | document_converter:_convert:473 | Finished converting document 00062205.pdf in 42.83 sec.
2026-01-29 22:33:05 | [33mWARNING [0m | document:export_to_markdown:5007 | Parameter `strict_text` has been deprecated and will be ignored.
2026-01-29 22:33:05 | [32mINFO    [0m | docling_utils:parse:145 | Successfully parsed 00062205.pdf: 64623 chars, 0 images, 27 pages
2026-01-29 22:33:05 | [32mINFO    [0m | ingest:ingest_pdf:343 | Skipping existing document: 00062205.pdf
2026-01-29 22:33:05 | [32mINFO    [0m | ingest:ingest_pdf:325 | Starting ingestion: 00070963.pdf
2026-01-29 22:33:05 | [32mINFO    [0m | docling_utils:parse:125 | Parsing PDF: 00070963.pdf (hash: 2b0f46e6...)
2026-01-29 22:33:05 | [32mINFO    [0m | document:_guess_format:538 | detected formats: [<InputFormat.PDF: 'pdf'>]
2026-01-29 22:33:05 | [32mINFO    [0m | document_converter:_convert:449 | Going to convert document batch...
2026-01-29 22:33:05 | [32mINFO    [0m | base_pipeline:execute:65 | Processing document 00070963.pdf
2026-01-29 22:34:24 | [32mINFO    [0m | document_converter:_convert:473 | Finished converting document 00070963.pdf in 79.42 sec.
2026-01-29 22:34:24 | [33mWARNING [0m | document:export_to_markdown:5007 | Parameter `strict_text` has been deprecated and will be ignored.
2026-01-29 22:34:24 | [32mINFO    [0m | docling_utils:parse:145 | Successfully parsed 00070963.pdf: 158081 chars, 0 images, 49 pages
2026-01-29 22:34:24 | [32mINFO    [0m | ingest:ingest_pdf:343 | Skipping existing document: 00070963.pdf
2026-01-29 22:34:24 | [32mINFO    [0m | ingest:ingest_directory:670 | Ingestion complete: 4/4 successful, 158 sections, 0 structures, 116 new section types discovered

‚â°∆í√Ö√ë Medical Drug Monograph Ingestion System
==================================================

‚â°∆í√∂¬∫ Initializing PostgreSQL database...
--------------------------------------------------
Database: medical_rag@localhost
Œì¬£√† Database initialized successfully!

‚â°∆í√¥√ú Starting PDF Ingestion
--------------------------------------------------
Source: data/pdfs
Vision: disabled

Found 4 PDF files


==================================================
‚â°∆í√¥√® INGESTION SUMMARY
==================================================
Œì¬£√† Successful: 4
Œì¬•√Æ Failed: 0
‚â°∆í√¥√§ Sections created: 158
‚â°∆í√ª‚ïù‚à©‚ïï√Ö  Images extracted: 0
‚â°∆í¬∫¬º Structures detected: 0
Œì√Ö‚ñí‚à©‚ïï√Ö  Time elapsed: 257.1s
